242 related articles for article (PubMed ID: 16736533)
21. Site-specific PEGylation of protein disulfide bonds using a three-carbon bridge.
Balan S; Choi JW; Godwin A; Teo I; Laborde CM; Heidelberger S; Zloh M; Shaunak S; Brocchini S
Bioconjug Chem; 2007; 18(1):61-76. PubMed ID: 17226958
[TBL] [Abstract][Full Text] [Related]
22. Effect of protein adsorption on the transport characteristics of asymmetric ultrafiltration membranes.
Mochizuki S; Zydney AL
Biotechnol Prog; 1992; 8(6):553-61. PubMed ID: 1369038
[TBL] [Abstract][Full Text] [Related]
23. Comparison of strong anion-exchangers for the purification of a PEGylated protein.
Pabst TM; Buckley JJ; Ramasubramanyan N; Hunter AK
J Chromatogr A; 2007 Apr; 1147(2):172-82. PubMed ID: 17346720
[TBL] [Abstract][Full Text] [Related]
24. Native protein-initiated ATRP: a viable and potentially superior alternative to PEGylation for stabilizing biologics.
Depp V; Alikhani A; Grammer V; Lele BS
Acta Biomater; 2009 Feb; 5(2):560-9. PubMed ID: 18804423
[TBL] [Abstract][Full Text] [Related]
25. Size-exclusion separation of proteins using a biocompatible polymeric monolithic capillary column with mesoporosity.
Li Y; Tolley HD; Lee ML
J Chromatogr A; 2010 Dec; 1217(52):8181-5. PubMed ID: 21084091
[TBL] [Abstract][Full Text] [Related]
26. Polyethylene glycol conjugation of recombinant methioninase for cancer therapy.
Tan Y; Sun X; Xu M; An Z; Tan X; Han Q; Miljkovic DA; Yang M; Hoffman RM
Protein Expr Purif; 1998 Feb; 12(1):45-52. PubMed ID: 9473456
[TBL] [Abstract][Full Text] [Related]
27. Structure-function engineering of interferon-beta-1b for improving stability, solubility, potency, immunogenicity, and pharmacokinetic properties by site-selective mono-PEGylation.
Basu A; Yang K; Wang M; Liu S; Chintala R; Palm T; Zhao H; Peng P; Wu D; Zhang Z; Hua J; Hsieh MC; Zhou J; Petti G; Li X; Janjua A; Mendez M; Liu J; Longley C; Zhang Z; Mehlig M; Borowski V; Viswanathan M; Filpula D
Bioconjug Chem; 2006; 17(3):618-30. PubMed ID: 16704199
[TBL] [Abstract][Full Text] [Related]
28. Characterization of a protein conjugate using an asymmetrical-flow field-flow fractionation and a size-exclusion chromatography with multi-detection system.
Rebolj K; Pahovnik D; Zagar E
Anal Chem; 2012 Sep; 84(17):7374-83. PubMed ID: 22876760
[TBL] [Abstract][Full Text] [Related]
29. Purification of singly PEGylated α-lactalbumin using charged ultrafiltration membranes.
Ruanjaikaen K; Zydney AL
Biotechnol Bioeng; 2011 Apr; 108(4):822-9. PubMed ID: 21404256
[TBL] [Abstract][Full Text] [Related]
30. Gas-phase proton-transfer chemistry coupled with TOF mass spectrometry and ion mobility-MS for the facile analysis of poly(ethylene glycols) and PEGylated polypeptide conjugates.
Bagal D; Zhang H; Schnier PD
Anal Chem; 2008 Apr; 80(7):2408-18. PubMed ID: 18324791
[TBL] [Abstract][Full Text] [Related]
31. Carbohydrate-specifically polyethylene glycol-modified ricin A-chain with improved therapeutic potential.
Youn YS; Na DH; Yoo SD; Song SC; Lee KC
Int J Biochem Cell Biol; 2005 Jul; 37(7):1525-33. PubMed ID: 15833282
[TBL] [Abstract][Full Text] [Related]
32. PEG chain length impacts yield of solid-phase protein PEGylation and efficiency of PEGylated protein separation by ion-exchange chromatography: insights of mechanistic models.
Yoshimoto N; Isakari Y; Itoh D; Yamamoto S
Biotechnol J; 2013 Jul; 8(7):801-10. PubMed ID: 23788446
[TBL] [Abstract][Full Text] [Related]
33. Enhanced circulation half-life of site-specific PEGylated rhG-CSF: optimization of PEG molecular weight.
Zhai Y; Zhao Y; Lei J; Su Z; Ma G
J Biotechnol; 2009 Jul; 142(3-4):259-66. PubMed ID: 19497340
[TBL] [Abstract][Full Text] [Related]
34. Separation of positional isomers of mono-poly(ethylene glycol)-modified octreotides by reversed-phase high-performance liquid chromatography.
Park EJ; Lee KC; Na DH
J Chromatogr A; 2009 Nov; 1216(45):7793-7. PubMed ID: 19766229
[TBL] [Abstract][Full Text] [Related]
35. Structural characterization of PEGylated rHuG-CSF and location of PEG attachment sites.
Cindrić M; Cepo T; Galić N; Bukvić-Krajacić M; Tomczyk N; Vissers JP; Bindila L; Peter-Katalinić J
J Pharm Biomed Anal; 2007 Jun; 44(2):388-95. PubMed ID: 17448619
[TBL] [Abstract][Full Text] [Related]
36. Enhanced circulating half-life and antitumor activity of a site-specific pegylated interferon-alpha protein therapeutic.
Bell SJ; Fam CM; Chlipala EA; Carlson SJ; Lee JI; Rosendahl MS; Doherty DH; Cox GN
Bioconjug Chem; 2008 Jan; 19(1):299-305. PubMed ID: 18020402
[TBL] [Abstract][Full Text] [Related]
37. PEGylation of therapeutic proteins.
Jevsevar S; Kunstelj M; Porekar VG
Biotechnol J; 2010 Jan; 5(1):113-28. PubMed ID: 20069580
[TBL] [Abstract][Full Text] [Related]
38. Nanoscale protein pores modified with PAMAM dendrimers.
Martin H; Kinns H; Mitchell N; Astier Y; Madathil R; Howorka S
J Am Chem Soc; 2007 Aug; 129(31):9640-9. PubMed ID: 17636906
[TBL] [Abstract][Full Text] [Related]
39. Native PAGE eliminates the problem of PEG-SDS interaction in SDS-PAGE and provides an alternative to HPLC in characterization of protein PEGylation.
Zheng C; Ma G; Su Z
Electrophoresis; 2007 Aug; 28(16):2801-7. PubMed ID: 17702059
[TBL] [Abstract][Full Text] [Related]
40. Characterization of polyether mixtures using thin-layer chromatography and matrix-assisted laser desorption/ionization mass spectrometry.
Watanabe T; Kawasaki H; Kimoto T; Arakawa R
Rapid Commun Mass Spectrom; 2007; 21(5):787-91. PubMed ID: 17279480
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
